Novel ECHS1 mutation in an Emirati neonate with severe metabolic acidosis

Metab Brain Dis. 2016 Oct;31(5):1189-92. doi: 10.1007/s11011-016-9842-x. Epub 2016 May 25.

Abstract

ECHS1 is a mitochondrial matrix enzyme that catalyzes an important step in the β-oxidation spiral of fatty acid catabolism, and individuals with mutations in the ECHS1 gene suffer from an autosomal recessive condition typified by delayed psychomotor development, mitochondrial encephalopathy, hypotonia, and cardiomyopathy. Here we report the first Arab case of ECHS1 Deficiency. The patient was born to consanguineous parents with all growth parameters being low for gestational age, and was persistently desaturated. Cord blood gas and later blood analysis showed severe metabolic acidosis. Tandem MS revealed increased levels of valine, and Leucine/Isoleucine and decreased level of Glutamine. There was also a large patent ductus arteriosus with right to left shunt and a possible small muscular ventricular septal defect. Whole Exome Sequencing revealed a novel homozygous missense mutation in the ECHS1 gene; c.842 A > G (p.Glu281Gly). In-silico analysis suggests that the residue affected by this mutation may be involved in an important functional or structural role.

Keywords: Arab; Mitochondrial encephalopathy; SCEH; Short-chain enoyl-CoA hydratase.

Publication types

  • Case Reports
  • Review

MeSH terms

  • Acidosis / diagnosis*
  • Acidosis / genetics*
  • Amino Acid Sequence
  • Enoyl-CoA Hydratase / genetics*
  • Female
  • Humans
  • Infant, Newborn
  • Mutation / genetics*
  • Severity of Illness Index*
  • United Arab Emirates

Substances

  • ECHS1 protein, human
  • Enoyl-CoA Hydratase